Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-424317

Director sold 14,514 shares at $49.63 ($720,373)

  • Director acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

George Simeon · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-14 Exercise or conversion : show line 1 in the form 10b5-1 +30,000 $14.00 $420,000 30,000 D
2026-10-14 Sale : show line 2 in the form 10b5-1 −14,514 $49.63 $720,373 15,486 D
Open-market sales · 14,514 sh · avg $49.63 · $720,373

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-14 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −30,000 0 D
Loading xslF345X06/ownership.xml…